- Home
- IRWD
IRWD
Ironwood Pharmaceuticals Inc.
as 04-18-2025 1:38pm EST
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | N/A | IPO Year: | 2010 |
| Target Price: | $4.94 | AVG Volume (30 days): | 4.7M |
| Analyst Decision: | Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.01 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.59 - $8.45 | Next Earning Date: | 05-08-2025 |
| Revenue: | $351,410,000 | Revenue Growth: | -20.63% |
| Revenue Growth (this year): | -21.86% | Revenue Growth (next year): | -2.36% |
Stock Insider Trading Activity of Ironwood Pharmaceuticals Inc. (IRWD)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| John Minardo | IRWD | Chief Legal Officer | Feb 10 '25 | Sell | $1.76 | 38,938 | $68,530.88 | 408,132 | |
| MCCOURT Thomas A | IRWD | Chief Executive Officer | Feb 10 '25 | Sell | $1.76 | 139,064 | $244,752.64 | 1,160,634 | |
| Shetzline Michael | IRWD | SVP, CMO, Head-Res&Drug | Feb 10 '25 | Sell | $1.76 | 41,269 | $72,633.44 | 554,007 | |
| Silver Ronald | IRWD | Principal Accounting Officer | Feb 10 '25 | Sell | $1.76 | 12,048 | $21,204.48 | 279,655 | |
| Martini Gregory S. | IRWD | Chief Financial Officer | Feb 10 '25 | Sell | $1.76 | 12,052 | $21,211.52 | 183,810 |
Latest Ironwood Pharmaceuticals Inc. News
IRWD Breaking Stock News: Dive into IRWD Ticker-Specific Updates for Smart Investing
Zacks
3 days ago
Biotech Stock Roundup: BMY Down on Study Failure, VERV Up on Study Data & More News
Zacks
4 days ago
Ironwood Shares Tank on Regulatory Update for Apraglutide
MT Newswires
4 days ago
Wells Fargo Downgrades Ironwood Pharmaceuticals to Equalweight From Overweight, Adjusts Price Target to $1 From $7
MT Newswires
4 days ago
Jefferies Downgrades Ironwood Pharmaceuticals to Hold From Buy, Adjusts Price Target to $0.70 From $8
Pharmaceutical Technology
4 days ago
Ironwood’s shares sink as FDA demands new trial for lead drug
MT Newswires
5 days ago
Sector Update: Health Care Stocks Rise Late Afternoon
MT Newswires
5 days ago
Top Midday Decliners
MT Newswires
5 days ago
Sector Update: Health Care Stocks Rise Monday Afternoon
Compare IRWD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IRWD Ironwood Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.